Literature DB >> 20059493

Does the extreme skin sensitization potency of benzoquinone result from special chemistry?

David W Roberts1, Aynur O Aptula.   

Abstract

BACKGROUND: Benzoquinone is known to be an extreme skin sensitizer. Until now there has been no consideration of whether it owes its extreme skin sensitization potency to unique aspects of its chemistry or simply to its high reactivity as a Michael acceptor.
OBJECTIVES: To answer these questions, we have applied two mechanistic approaches to estimate a theoretical potency value for benzoquinone. PATIENTS/
METHODS: A mechanistic read-across (MRA) approach, using known potency data for moderate sensitizers in the Michael acceptor domain, and a published quantitative mechanistic model (QMM) for skin sensitization potency of Michael acceptors, all in the moderate and weak range, were used.
RESULTS: The read-across approach gives a theoretical local lymph node assay (LLNA) EC3 value of 0.04%, and the QMM approach gives a theoretical value of 0.013%, compared with an experimental value of 0.010%.
CONCLUSIONS: The good agreement between the theoretical and experimental EC3 values supports the strength of the MRA and QMM approaches, and provides strong evidence that the extreme sensitization potency of benzoquinone can be attributed solely to its high reactivity as a Michael acceptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20059493     DOI: 10.1111/j.1600-0536.2009.01646.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  2 in total

1.  Substituent effects on the reactivity of benzoquinone derivatives with thiols.

Authors:  Wilbes Mbiya; Itai Chipinda; Paul D Siegel; Morgen Mhike; Reuben H Simoyi
Journal:  Chem Res Toxicol       Date:  2012-12-27       Impact factor: 3.739

2.  Reactivity measurement in estimation of benzoquinone and benzoquinone derivatives' allergenicity.

Authors:  Wilbes Mbiya; Itai Chipinda; Reuben H Simoyi; Paul D Siegel
Journal:  Toxicology       Date:  2015-12-02       Impact factor: 4.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.